Skip to main content Skip to section navigation Skip to footer
  • For Physicians
  • For Patients
  • For Distributors
  • Investors
  • For Physicians
  • For Patients
  • For Distributors
  • Investors
IceCure
  • Clinical Applications
    • Breast Tumors
    • Kidney Cancer
    • Lung Cancer
    • Palliative Care
    • Fibroadenomas
  • Products
    • ProSense
    • User Manuals
  • Technology
  • Resources
    • Publications
    • Case Studies
    • Webinars
    • Videos
    • Blog
    • Media & Events
    • ICE3 Trial
  • Company
    • About Us
    • Careers
  • Contact
Menu
  • Clinical Applications
    • Breast Tumors
    • Kidney Cancer
    • Lung Cancer
    • Palliative Care
    • Fibroadenomas
  • Products
    • ProSense
    • User Manuals
  • Technology
  • Resources
    • Publications
    • Case Studies
    • Webinars
    • Videos
    • Blog
    • Media & Events
    • ICE3 Trial
  • Company
    • About Us
    • Careers
  • Contact
  • Clinical Applications
    • Breast Tumors
    • Kidney Cancer
    • Lung Cancer
    • Palliative Care
    • Fibroadenomas
  • Products
    • ProSense
    • User Manuals
  • Technology
  • Resources
    • Publications
    • Case Studies
    • Webinars
    • Videos
    • Blog
    • Media & Events
    • ICE3 Trial
  • Company
    • About Us
    • Careers
  • Contact
  • For Physicians
  • For Patients
  • For Distributors
  • Investors
Menu
  • Clinical Applications
    • Breast Tumors
    • Kidney Cancer
    • Lung Cancer
    • Palliative Care
    • Fibroadenomas
  • Products
    • ProSense
    • User Manuals
  • Technology
  • Resources
    • Publications
    • Case Studies
    • Webinars
    • Videos
    • Blog
    • Media & Events
    • ICE3 Trial
  • Company
    • About Us
    • Careers
  • Contact
  • For Physicians
  • For Patients
  • For Distributors
  • Investors

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Company Profile
    • Executive Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote and Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity
  • News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
Mar 27, 2024 8:30 am EDT

IceCure Medical to Report 2023 Full Year Financial & Operational Results on April 3, 2024

Mar 19, 2024 8:30 am EDT

IceCure Medical Reports Positive Topline Results From ICE3 Cryoablation Breast Cancer Study: Achievement of 96.39% Recurrence Free Rate Brings Company One Step Closer to Providing Women a Non-Surgical Alternative to Lumpectomy

Mar 12, 2024 8:30 am EDT

IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogen Flow Control to Optimize Patient Outcomes

Mar 07, 2024 8:30 am EST

IceCure Medical to Present at 34th Annual Oppenheimer Healthcare MedTech & Services Conference

Mar 04, 2024 8:30 am EST

IceCure's ProSense® a Promising Alternative Treatment for Extra-Pelvis Endometriosis: Independent Study Presented at ECR 2024

Feb 27, 2024 8:00 am EST

Fourth BRIIT Conference in India Features IceCure's ProSense® in Breast Cancer Imaging & Interventions Workshop

Feb 26, 2024 8:00 am EST

Study Using IceCure's ProSense® Treatment Results in 100% Tumor Reduction in Early-Stage Breast Cancer

Feb 15, 2024 8:00 am EST

IceCure's ProSense® to be Featured at Two Upcoming Medical Conferences in Japan

Jan 30, 2024 8:00 am EST

U.S. FDA Grants IceCure Medical's Appeal: Reopens De Novo Classification Request for Marketing Authorization of ProSense® for Early-Stage Breast Cancer

Jan 29, 2024 8:00 am EST

IceCure Medical's Breast Cryoablation Gains Prominence in the U.S., as Society of Interventional Oncology Annual Meeting Features its First Breast Cryoablation Master Class

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 17
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
  • Sitemap
IceCure

IceCure Medical HQ: 7 Ha’Eshel St., PO Box 3163, Caesarea, 3079504, Israel

Facebook-f Tiktok Twitter Linkedin-in Instagram Youtube
© 2025 All Rights Reserved IceCure Medical
Facebook-f Tiktok Twitter Linkedin-in Instagram Youtube
Branding by Titan
Terms of Use    |    Privacy    |    Last Updated: April 9, 2023

We use cookies to offer you a better browsing experience, including personalized advertising. By continuing to use the site you agree to their use.